GOLDEN THROAT: 2024 Interim Report

HKEXSep 25 17:06 · Announcements

Hong Kong stock opportunities tracking | Ctrip's second-quarter net profit was 3.833 billion yuan, a year-on-year increase of over 507%; Beigene's first-half revenue was 1.681 billion US dollars, a year-on-year growth of about 61%

Several banks in Hong Kong have lowered the interest rates on Hong Kong dollar deposits; members of the Federal Open Market Committee (FOMC) stated that the time to cut interest rates has come, and it is hard to imagine any surprises at the September meeting.

Futu NewsAug 27 08:24

Golden Throat Reports Robust Mid-Year Growth

TipRanksAug 26 20:39

The options holder of Golden Throat (06896.HK) saw a year-on-year increase of approximately 9.9% in attributable surplus to approximately 0.134 billion yuan.

Guangdong Hui announced on August 26 that as of the six months ended June 30, 2024, the Group's revenue increased by approximately 9.4% to approximately RMB 0.52 billion compared to the same period last year. The profit attributable to equity holders of the company increased by approximately 9.9% to approximately RMB 0.134 billion for the six months ended June 30, 2023. The board of directors does not recommend the declaration of any interim dividend for the six months ended June 30, 2024. The increase in group revenue was mainly due to the increase in sales of the Golden Throat throat lozenges (OTC) in the first half of 2024. As of June 30, 2024.

Gelonghui FinanceAug 26 20:23

Golden Throat (06896) announced its interim performance, with a net profit of approximately 0.134 billion yuan, a year-on-year increase of approximately 9.9%.

Golden Throat (06896) announced its mid-year performance in 2024, with revenue of approximately 0.5245 billion yuan, a year-on-year growth of about 9.4...

Zhitong FinanceAug 26 20:10

GOLDEN THROAT: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024

HKEXAug 26 20:07 · Announcements